Company: PACB
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001299130-25-000168
Chunk: 37

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 37
---
 Notes, using the if-converted method, and outstanding equity awards using the treasury stock method.

Q3 Fiscal 2025 Form 10-Q24

The following table presents the calculation of the basic and diluted net loss per share amounts presented in the condensed consolidated statements of operations and comprehensive loss:Three Months Ended September 30,Nine Months Ended September 30,(In thousands, except per share amounts)2025202420252024Numerator:Net loss$(38,000)$(60,725)$(506,005)$(312,222)Denominator:BasicWeighted average shares used in computingbasic net loss per share300,844272,915299,303271,631Basic net loss per share$(0.13)$(0.22)$(1.69)$(1.15)DilutedWeighted average shares used in computingdiluted net loss per share300,844272,915299,303271,631Diluted net loss per share$(0.13)$(0.22)$(1.69)$(1.15)The following shares issuable upon conversion of the Notes and outstanding equity awards were excluded from the computation of diluted net loss per share for the periods presented because the effect of including such shares would have been antidilutive:Three Months Ended September 30,Nine Months Ended September 30,(In thousands)2025202420252024Shares issuable upon conversion ofconvertible senior notes61,41531,06361,41531,063Equity awards42,59936,49642,59936,496See Note 7. Equity Plans and Share-Based Compensation for detailed information on equity awards.

NOTE 9.  SEGMENT AND GEOGRAPHIC INFORMATIONWe are organized as, and operate in, one reportable segment: the development, manufacturing, and marketing of integrated platforms for genetic analysis. Our chief operating decision-maker ("CODM") is our Chief Executive Officer. Our CODM reviews financial information presented on a consolidated basis for the purposes of evaluating financial performance and allocating resources.On a regular basis, our CODM reviews:•total revenues by category•total expenses and expenses by function, including sales and marketing and general and administrative, which include depreciation and share-based compensation•net loss per shareOur assets are primarily located in the United States of America and not allocated to any specific region, and we do not measure the performance of geographic regions based upon asset-based metrics. Therefore, geographic information is presented only for revenue.

Q3 Fiscal 202